pSivida and Cirrus to work together on new drug formulations
8th Sep 2005, 00:52 GMT
Australia-based nanotechnology firm pSivida is to collaborate with US-based pharmaceutical company Cirrus Pharmaceuticals to accelerate and expand development of a number of specific drug candidates formulated in pSivida's drug delivery substance, BioSilicon.
Latest news from Pharmaceutical Business Review Online:
- Celesio revenues, profits up
- Amgen arthritis drug shows sustained safety and efficacy
- Study supports cardiovascular safety of naproxen
- Cangene chickenpox drug granted orphan status
- Reata brain cancer therapy shows strong activity
- Novartis diabetes drug faces three month delay
- Favrille drug fails secondary goal
- Neurogen commences human testing of obesity drug
- Aeterna prostate cancer drug shows promise
- Isis says new drug effective against cholesterol